Ask Onix
Decades of work condensed into years
The global orchid market, valued at hundreds of millions of dollars, thrives on novelty-but developing a new variety traditionally takes up to a decade. Dutch breeding firm Floricultura is now using genetic tools to slash that timeline, though the process remains labor-intensive and highly competitive.
A genetic mess complicates traditional breeding
Centuries of selective breeding have left commercial orchids with chaotic genetic backgrounds, making it nearly impossible to predict traits like color, shape, or disease resistance in new hybrids. Floricultura's R&D manager, Wart van Zonneveld, describes the current genetic landscape as a "disaster."
To navigate this unpredictability, breeders are turning to genetic markers-tools that flag desired traits in young plants before they mature. Instead of waiting three years for a hybrid to flower, companies can now screen thousands of seedlings early and discard those lacking the right genetic signatures.
"If a few thousand cross breeds come from the lab, we can screen them based on the marker and just select the ones that have the trait we're searching for."
Wart van Zonneveld, Floricultura
Trade secrets and intellectual property
Novel breeding techniques are closely guarded. Each company develops proprietary genetic markers, as uniqueness is key to standing out in a crowded market. "We keep it to ourselves because it's a lot of investment," van Zonneveld says.
Paul Arens, a researcher at Wageningen University, notes that while genetics streamline the process, traditional breeding fundamentals remain unchanged: "You take two plants, look at their characteristics, and make a cross." The difference today? Breeders now wear lab coats and use genomics to guide their selections.
Intellectual property protection is critical. In Europe, new varieties are safeguarded through breeders' rights, while the U.S. relies on patents. To qualify, a plant must be distinct, stable, and uniform-criteria assessed through physical traits, not DNA. However, genetic analysis helps determine which existing varieties a new plant should be compared against.
"It's just like forensic science. You run markers at different DNA positions to create a pattern and see if it matches."
Paul Arens, Wageningen University
From lab to greenhouse: A nine-year journey
After genetic screening, selected seedlings spend three years growing-first in labs, then in greenhouses-before facing further evaluation. Stefan Kuiper, Floricultura's breeding manager, calls the process "the art of throwing away," as breeders discard plants that fail to meet their standards. The survivors are then cloned using meristems, the cells responsible for a plant's growth.
Orchid cultivation is resource-intensive, requiring precise control over heat, light, water, and nutrients. Even with advanced techniques, the plants must grow naturally to confirm traits like flower shape, color, and disease resistance. Floricultura's greenhouses span seven hectares in Heemskerk, Netherlands, where automated systems transport trays of plants through various growth stages.
The company also prioritizes sustainability. Rainwater is harvested from greenhouse roofs, and a geothermal well-tapping water at 102°C from 3 km underground-powers operations and may soon supply district heating to the local community.
The final judgment: Human eyes decide
Despite technological advances, the ultimate decision to add a new variety to Floricultura's catalog rests with Kuiper and his team. A plant may meet all genetic criteria, but it must also be visually stunning to sell. "Breeding is a little bit like gambling," Kuiper says. "For now, that human element remains."
With over 180 varieties in their catalog and hundreds more in development, Floricultura's work never stops. "You can't pause," Kuiper warns. "It takes so long to develop new varieties that if you do, you'll fall behind."
